Skip to main content
Clinical and Translational Allergy logoLink to Clinical and Translational Allergy
. 2025 Jan 25;15(1):e70018. doi: 10.1002/clt2.70018

Socioeconomic status has direct impact on asthma control: Turkish adult asthma registry

Bahar Arslan 1,2, Murat Türk 1,, Serhat Hayme 3, Ömür Aydin 4, Derya Gokmen 5, Gozde Koycu Buhari 6, Zeynep Celebi Sozener 4,7, Bilun Gemicioglu 8, Ismet Bulut 9, Sengul Beyaz 7,10, Cihan Orcen 11, Secil Kepil Ozdemir 12, Metin Keren 9, Ebru Damadoglu 13, Tugce Yakut 14, Ayse Fusun Kalpaklioglu 15, Ayse Baccioglu 15, Sumeyra Alan Yalim 15, Insu Yilmaz 1, Ilkay Koca Kalkan 6, Elif Yelda Ozgun Niksarlioglu 16, Ali Fuat Kalyoncu 13, Gul Karakaya 13, Muge Erbay 17, Sibel Nayci 18, Fatma Merve Tepetam 9, Asli Akkor Gelincik 10, Hulya Dirol 19, Ozlem Goksel 20, Selen Karaoglanoglu 21, Ferda Oner Erkekol 22,23, Sacide Rana Isik 24, Fusun Yildiz 25,26, Yasemin Yavuz 5, Dilek Karadogan 27, Nurgul Bozkurt 19, Ummuhan Seker 28, Ipek Kivilcim Oguzulgen 29, Ilknur Basyigit 25, Serap Argun Baris 25, Elif Yilmazel Ucar 30, Tuba Erdogan 31, Mehmet Polatli 32, Dane Ediger 33, Fatma Esra Gunaydin 33, Leyla Pur 34, Zeynep Yegin Katran 9, Yonca Sekibag 8, Enes Furkan Aykac 8, Dilsad Mungan 4, Ozcan Gul 4, Ali Cengiz 4, Bulent Akkurt 12, Seyma Ozden 9, Semra Demir 10, Derya Unal 10, Ayse Feyza Aslan 10, Ali Can 10, Reyhan Gumusburun 20, Gulhan Bogatekin 20, Hatice Serpil Akten 20, Sinem Inan 20, Munevver Erdinc 35, Aliye Candan Ogus 19, Murat Kavas 9, Demet Polat Yulug 36, Mehmet Erdem Cakmak 13, Saltuk Bugra Kaya 13, Gulistan Alpagat 15, Eylem Sercan Ozgur 19, Oguz Uzun 37, Sule Tas Gulen 32, Gulseren Pekbak 33, Deniz Kizilirmak 38, Yavuz Havlucu 38, Halil Donmez 39, Gulden Pacaci Cetin 1,11, Sadan Soyyigit 22, Bilge Yilmaz Kara 27, Gulden Pasaoglu Karakis 40, Adile Berna Dursun 39,41, Resat Kendirlinan 42, Ayse Bilge Ozturk 43, Can Sevinc 44, Gokcen Omeroglu Simsek 44, Oznur Abadoglu 45, Pamir Cerci 46, Taskin Yucel 47, Irfan Yorulmaz 48, Zahide Ciler Tezcaner 48, Emel Cadalli Tatar 49, Ahmet Emre Suslu 48,50, Serdar Ozer 47, Engin Dursun 51, Arzu Yorgancioglu 38, Gulfem Elif Celik 4, Mehmet Atilla Uysal 16
PMCID: PMC11761715  PMID: 39865387

Abstract

Background

Asthma is one of the most common causes of chronic respiratory disease, and countries with low socioeconomic status have both a high prevalence of asthma and asthma‐related death.

Objective

In this study, we aimed to determine socioeconomic levels of asthmatic patients according to a national database and investigate the effects of social markers on disease control in our region.

Methods

This is an analysis of data from 2053 adult asthma patients from a multicentre chart study in Turkey. Socioeconomic status (SES) data were collected from questionnaires and this form was sent to the patients via e‐mail. Parameters related to social status and poor disease control were analyzed.

Results

Illiteracy (OR:2.687 [95% CI: 1.235–5.848]; p = 0.013) and lower household income (OR:1,76 [95% CI: 1.002–3.09]; p = 0.049) were found as independent risk factors for hospitalization in the multivariate logistic regression analysis. Therewithal, being aged between 40 and 60 (OR: 1.435 [95% CI: 1.074–1.917]; p = 0.015), illiteracy (OR: 2.188 [95% CI: 1.262–3.795]; p = 0.005) and being employed (OR: 1.466 [95% CI: 1.085–1.847]; p = 0.011) were considered as independent risk factors for systemic corticosteroid use at least 3 days within last 1 year.

Conclusion

As a result of our national database, education level, household income and working status briefly socioeconomic status have impacts on asthma control. Identification of social markers in asthma and better recognition of risk factors based on the population gives us clues to provide better asthma control in the future.

Keywords: asthma, asthma control, education level, household income, illiteracy, national database, social markers, socioeconomic status

1. INTRODUCTION

Asthma, a chronic respiratory disease, affects approximately 1%–18% of the population worldwide. 1 According to the Global Burden of Disease, 495,100 individuals died of asthma in 2017 worldwide. 2 Although asthma is more prevalent in high‐income countries, the majority of asthma‐related deaths occur in low‐ and middle‐income countries. Global efforts aimed at improving asthma diagnosis and treatment have not benefitted the most vulnerable communities. Significant challenges related to accurate diagnosis, the availability of effective treatments, and access to specialized care exist in most regions of the world. 3

Socioeconomic status (SES) is an ambiguous term, and its scope has been determined differently across studies. It is the individual's position on the socioeconomic scale, determined by a combination of social and economic factors such as education level, household income, and insurance status. 4 SES plays a significant role in determining health and nutritional status along with mortality and morbidity. Asthma prevalence tends to be higher in lower socioeconomic groups, particularly those with lower disease control status, than that in higher socioeconomic groups. 5 , 6 Lower SES individuals may be more exposed to environmental triggers such as pollution, tobacco smoke, and allergens owing to living in suboptimal housing conditions or neighborhoods with poor air quality than those from higher SES. 7 Individuals with lower income were more likely to experience adverse asthma outcomes independent of education, perceived stress, race, and medication adherence 8 Additionally, there is a substantial correlation between low levels of education and limited asthma knowledge. Ineffective inhaler use, adherence challenges, and limited knowledge regarding asthma action plans and triggers make asthma management difficult in these patients. 9 Consequently, groups with low SES have higher rates of poor asthma control, hospital admissions, severe diseases, and asthma‐related deaths than those in groups with high SES. 10 , 11

Even though several studies have previously investigated the impact of SES on the health outcomes associated with asthma, these varied widely in their study populations, regions, healthcare systems, and methodologies. Studies aimed to assess the effects of SES on asthma in Turkish patients are scarce and conducted on a limited number of patients. 12 , 13 Having detailed information regarding the national asthma characteristics can offer treatment opportunities with a social integrative approach, and can guide in both disease management and risk stratification. Thus, this multicenter study aimed to determine the socioeconomic levels of patients with asthma according to a national registry and investigate the effects of social markers on disease control in Turkey.

2. METHODS

2.1. Turkish adult asthma registry

This is an analysis of data from a multicenter chart study and presents findings from a national registry on adult asthma, with entries recorded between March 2018 and March 2022 in Turkey. After the establishment of the idea of the registry, first, an invitation letter prepared by the study coordinator was e‐mailed to all members of the Asthma Working Group of the Turkish Thoracic Society. The requirement of being a study center was either secondary or tertiary hospitals with regular follow‐up patients with asthma. Finally, a total of 36 centers participated, and data from 2053 patients were recorded in the registry. SES data were collected from questionnaires standardized by the asthma database working group. 14

2.2. Study patients

The study included patients aged 18 years and above, with confirmed asthma diagnoses based on both the Global Initiative for Asthma (GINA) and a minimum of 1 year of follow‐up, and provided informed consent. The study was approved by the Ankara University Ethics Committee (Approval no: 16–10 l I‐I7/2017).

2.2.1. Study parameters and definitions

All parameters were collected from the national asthma database study. 14 The study variables and outcomes were defined in a standardized manner based on guidelines by the study executive committee, and written instructions were mailed to all study investigators before data enrollment to the registry. The investigators were asked to enter the data in the registry. Non‐standardized data were neither entered nor accepted. Patient records were utilized as the data source. The database was used to collect the following information: Parameters related to social status: age, gender, place of birth (urban‐rural), place of residence (urban‐rural), marital and employment status, household income, education level, smoking history, and body mass index (BMI). Parameters related to poor disease control: parameters related to disease activity (exacerbation and hospitalization rates, and systemic steroid requirement related to asthma in the last year); and GINA asthma control category.

Asthma control was evaluated based on both the GINA assessment and asthma control test (ACT) categories. 1 , 15 , 16 ACT is a validated patient‐reported asthma control measure consisting of five questions that assess activity limitation, shortness of breath, night‐time symptoms, use of rescue medications, and the patient's overall assessment of asthma control during the past 4 weeks. The sum of the responses to the questions is the ACT score, graded from 1 (worst) to 5 (best). The best score on the ACT is 25, and the worst is 5. Scores of 20–25, 16–19, and 5–15 are classified as well‐controlled, not well‐controlled, and very poorly controlled asthma, respectively. 15 , 16 The GINA symptom control tool (categorical classification) assesses the frequency of daytime symptoms, any night waking due to asthma or activity limitation, and frequency of the use of short‐acting beta agonist (SABA) reliever for symptom relief in patients in the past 4 weeks. Categorical classification ranges from 0 to 4, 0 indicating well‐controlled asthma, 1–2 partly controlled asthma, and 3–4 uncontrolled asthma. 1

Combined household income level was collected as “Minimum wage and below,” “Between 2 and 4 times the minimum wage” and “>4 times the minimum wage.” The minimum wage is defined as “the lowest income necessary to meet a typical family's basic needs.” For univariate and multivariate analyses, education level was grouped as “illiterate,” “8 years of education and below” and “over 8 years of education.”

2.3. Statistical analysis

Data were described using either frequency (percentage) for categorical data or mean ± standard deviation (minimum‐maximum) for metric variables. Assumptions of normality and homogeneity of variances are assessed using the Kolmogorov–Smirnov and Levene tests, respectively. When comparing numerical variables, a Student t‐test was used to compare two groups, while group comparisons were conducted using Pearson's chi‐squared analysis for categorical variables.

Univariate and multivariable logistic regression analyses were used to define the risk factors for patients who used and did not use systemic corticosteroids for at least 3 days, those with and without hospitalization, and those with and without intensive care admission. The p‐value for inclusion in the multiple regression model was set at 0.20. Statistically significant value was set as p < 0.05. The IBM SPSS 22.0 software package (SPSS Inc., Chicago, IL, USA) was used to conduct the statistical analysis.

3. RESULTS

3.1. Patients' characteristics and disease control status

Table 1 presents the baseline characteristics of 2053 patients. Among them, the majority (n = 1535; 74.8%) were women. The mean age of the patients was 46.7 ± 14.7 years, with approximately 50% belonging to the 40–60 years age group (n = 1020; 50.1%).

TABLE 1.

Demographics and socioeconomic status (SES) of the patients included in the study.

Variables N
Gender; n (%)
Female 1535 (74.8)
Male 518 (25.2)
Age; mean year ±SD 46.7 ± 14.7
Age groups; n (%)
18–39 years 639 (31.4)
40–60 years 1020 (50.1)
≥60 years 375 (18.4)
Marital status; n (%)
Married 778 (37.9)
Single 223 (10.9)
Divorced 42 (2)
Level of education; n (%)
Illiterate 83 (4.3)
No school, literate 30 (1.6)
Primary school 766 (39.9)
High school 451 (23.5)
Collage/University 588 (30.7)
Employment; n (%)
Government officer 279 (14.4)
Self‐employed 256 (13.2)
Housewife 795 (41)
Student 147 (7.6)
Retired 189 (9.7)
Unemployed 93 (4.8)
Body mass index; mean ± SD 28.1 ± 5.6
Body mass index groups; n (%)
≤18.49 (weak) 38 (1.9)
18.50–24.99 (normal) 569 (27.7)
25–29.99 (overweight) 693 (33.8)
30–34.99 (1st degree obese) 407 (19.8)
35–39.99 (2nd‐degree obese) 145 (7.1)
≥40 (3rd degree obese) 67 (3.3)
Smoking history; n (%)
Never smoked 1364 (68,1)
Currently smoker 228 (11.4)
Ex‐smoker 410 (20.5)
Cigarette; mean package/years ±SD 14 ± 22.2
Place of birth; n (%)
Urban 1136 (55.3)
Rural 800 (39)
Place of residence; n (%)
Urban 1854 (90.3)
Rural 117 (5.7)
Household income; n (%)
Minimum wage and below 386 (21.8)
Between 2 and 4 times the minimum wage 846 (41.2)
>4 times the minimum wage 540 (26.3)

Abbreviation: SD, standard deviation.

3.2. SES outcomes of the study group

The majority of the patients included were unemployed, 41% (n = 795) were housewives, and the highest grade of education in 40% (n = 766) was a primary school. The vast majority of patients were born and residents of an urban area (n = 1136 [55.3%] and n = 1854 [90.3%], respectively). The household income of the participants was low and mostly 2–4 times the minimum living wage (n = 560; 61.7%) (Table 1). The majority of the patients were using ICS/LABA combinations (n = 1811, 88%) and on GINA step 3–5 treatments [n = 443 (25.6%), n = 388 (22.4%), and n = 694 (40.1%).

3.3. Asthma control status

Approximately one‐third of the patients (n = 671, 32.6%) were diagnosed with severe asthma, while 934 participants (46%) exhibited well‐controlled asthma based on GINA assessment. Regarding disease activity in the past year, 25% (n = 431), 27.3% (n = 482), 8.7% (n = 150), and 1.2% (n = 20) had a history of exacerbations requiring at least 3 days of systemic corticosteroid use, a history of emergency service admission, hospitalized due to asthma, and were followed up in an intensive care unit (ICU) within the last year, respectively (Table 2). Of the 171 patients (41.5%) who visited the emergency room once owing to asthma, 71 had severe asthma, and 184 of the 311 patients (58.2%) who visited the emergency room twice or more in the previous year had severe asthma.

TABLE 2.

Clinical characteristics of the included patients.

Variable N
Disease duration; mean years ±SD 12.9 ± 10.34
Presence of severe asthma; n (%) 670 (32.6)
Asthma control, n (%) (GINA assessment)
Well controlled 934 (46.4)
Partial controlled 610 (30.3)
Uncontrolled 468 (23.3)
Exacerbations requiring at least 3 days of use of OCS in the last year; n (%) 431 (24.5)
Presence of emergency service admission due to asthma in the last 1 year; n (%) 482 (27.3)
Presence of hospitalization due to asthma in the last 1 year; n (%) 150 (8.7)
Presence of intensive care hospitalization due to asthma in the last 1 year; n (%) 20 (1.2)

3.4. SES factors and their associations with asthma control

Household income and level of education directly affect asthma control and with their increase, the percentage of patients with well‐controlled asthma increases (Table 3).

TABLE 3.

Effects of household income and education level on the asthma control test (ACT) scores.

Asthma control test scores
5–15 16–19 20–25 p
Household income
Minimum wage and below 84 (26.2) 64 (19.9) 173 (53.9) <0.001
Between 2 and 4 times the minimum wage 146 (20.6) 170 (24) 392 (55.4)
>4 times the minimum wage 75 (16.6) 78 (17.3) 299 (66.2)
Level of education
Illiterate 24 (35.3) 12 (17.6) 32 (47.1) 0.007
8 years of education and below 146 (21.9) 141 (21.2) 379 (56.9)
Over 8 years 155 (18.2) 168 (19.7) 528 (62)

Note: Bold values denote statistical significance at the p < 0.05 level.

3.5. Age, level of education, and employment status affect the need for using systemic corticosteroids

Based on their education levels, age groups, and working status, differences were observed among patients who required systemic steroids for at least 3 days within the last year and those who did not (Table 4). The former group was older and had a lower level of education and a higher rate of employment.

TABLE 4.

General characteristics of patients who used and did not use steroids for asthma for at least 3 days.

Variable With systemic corticosteroid use for at least 3 days No systemic corticosteroid use p
Female gender; n (%) 327 (76) 994 (75) 0.653
Age; mean years ±SD 48.3 ± 13.5 46.8 ± 14.8 0.054
Age group; n (%)
18–39 110 (25.8) 418 (31.7) 0.028
40–65 240 (56.2) 648 (49.2)
≥65 77 (18) 252 (19.1)
Place of residence (rural/Urban) 25/391 77/1196 0.977
Level of education; n (%)
Illiterate 26 (6.4) 43 (3.4) 0.028
8 years and below 175 (43.3) 545 (43.4)
over 8 years 203 (23.3) 667 (53.1)
Occupation; n (%)
Employee (officer, self‐employed other) 165 (40.4) 434 (34.1) 0.021
Unemployed (student, retired, housewife, or unemployed) 243 (59.6) 837 (65.9)
BMI; n (%)
<30 261 (64.9) 862 (67.7) 0.3
≥30 (obese) 141 (35.1) 411 (32.3)
BMI; mean ± SD 28.5 ± 5.9 28.1 ± 5.5 0.156
Smoking history; n (%)
Never smoked 39 156 0.066
Currently smoker 102 258
Ex‐smoker 278 898
Cigarette (package/year) (mean ± SD) (median, min‐max) 13.9 ± 21.4 14.3 ± 23.6 0.857
Household income
Minimum wage and below 48 (25.1) 153 (27) 0.594
Between 2 and 4 times the minimum wage 113 (59.2) 340 (60.1)
>4 times the minimum wage 30 (15.7) 73 (12.9)

Note: Bold values denote statistical significance at the p < 0.05 level.

In multivariate logistic regression analysis, age between 40 and 60 years (odds ratio [OR]: 1.435 [95% confidence interval [CI]: 1.074–1.917]; p = 0.015), illiteracy (OR: 2.188 [95% CI: 1.262–3.795]; p = 0.005), and employment (OR: 1.466 [95% CI: 1.085–1.847]; p = 0.011) were considered as independent risk factors for systemic corticosteroid use at least 3 days within last 1 year (see eTable 1).

3.6. SES factors associated with hospitalization in the last year owing to asthma

Within the last year, 150 patients (8.7%) were hospitalized owing to asthma exacerbation. These patients had a higher BMI (29.4 ± 6.6 vs. 28.1 ± 5.5; p = 0.021), were more likely to be born in rural areas (49.6% vs. 40.9%; p = 0.047), and had lower household income when compared with those without hospitalization (Table 5).

TABLE 5.

General characteristics of patients with and without hospitalization.

Variable With hospitalization Without hospitalization p
Gender, female; n (%) 119 (79.3) 1172 (74.6) 0.197
Age; mean years ±SD 47.08 ± 13.9 47.2 ± 14.5 0.934
Age group; n (%)
18–39 44 (29.3) 471 (30.2) 0.934
40–65 79 (52.7) 796 (51.1)
≥65 27 (18) 291 (18.7)
Level of education; n (%)
Illiterate 13 (9.2) 53 (3.6) 0.001
8 years and below 69 (48.6) 639 (43.2)
Over 8 years 60 (42.3) 787 (53.2)
Occupation; n (%)
Employee (officer, self‐employed other) 50 (34.2) 535 (35.7) 0.732
Unemployed (student, retired, housewife, or unemployed) 96 (65.8) 965 (64.3)
BMI; n (%)
<30 84 (60.4) 1015 (67.7) 0.081
≥30 (obese) 55 (39.6) 484 (32.3)
BMI; mean ± SD 29.4 ± 6.6 28.1 ± 5.5 0.021
Number of people in the household median (min‐max) 3 (1–10) 3 (1–11) 0.254
Smoking status; n (%)
Current smoker 17 176 0.357
Ex‐smoker 38 324
Never smoked 92 1049
Place of birth (urban/rural) 70/69 881/611 0.047
Place of residence (urban/rural) 132/14 1420/87 0.066
Household income; n (%)
Minimum wage and below 19 (34.5) 180 (26.7) 0.375
Between 2 and 4 times the minimum wage 28 (50.9) 406 (60.1)
>4 times the minimum wage 8 (14.5) 89 (13.2)
Household income; n (%) 0.005
Under 1000 TL 9 (6.9) 112 (8.1)
1000–2000 TL 32 (24.6) 187 (13.6)
2000–5000 TL 60 (46.2) 654 (47.6)
Over 5000 TL 29 (22.3) 422 (30.7)

Note: Bold values denote statistical significance at the p < 0.05 level.

In the multivariate logistic regression analysis, only illiteracy (OR: 2.687 [95% CI: 1.235–5.848]; p = 0.013) and lower household income (OR: 1,76 [95% CI: 1.002–3.09]; p = 0.049) were found as independent risk factors for hospitalization (see eTable 2).

3.7. Differences in education level, place of birth, and place of residence in patients followed up at ICUs

Only a small number of patients required ICU support due to asthma exacerbation (n = 20, 1.2%). Noteworthy differences were observed in education levels, place of birth, and place of residence between patients requiring ICU support for asthma and those who did not. In univariate analyses, the rate of intensive care hospitalization was higher in those who were illiterate (OR: 10,64 [95% CI: 2.327–45.65]; p = 0.002) and with less than 8 years of education (OR: 3666 [95% CI: 1.177–11.41]; p = 0.025) than in others. Additionally, it was more common for patients born in rural areas (OR: 4.29 [95% CI: 1.554–11.884]; p = 0.005) and those still residing in urban areas (OR: 7.081 [95% CI: 1.554–11.884]; p < 0.001) in univariate analyses. However, multivariate analysis could not be performed owing to statistical limitations.

4. DISCUSSION

This was one of the most comprehensive studies involving a substantial number of Turkish adult patients with asthma. This study's results demonstrate the significant impact of social factors, particularly education level and household income, on asthma control in terms of the ACT score, hospitalization rates, and the need for systemic corticosteroids. We observed that illiteracy is a risk factor for both the use of systemic steroids for at least 3 days and hospitalization; moreover, low household income is also a risk factor for hospitalization. It was also observed that better asthma control was achieved as education level and household income increased.

When the social profile of Turkish patients with asthma was evaluated, the education level demonstrated heterogeneous distribution; however, the most common education level was primary school, and the majority of patients were living in urban areas with a BMI above normal. The majority of patients were concentrated in middle and low‐income levels (minimum wage and below, between 2 and 4 times the minimum wage) and were not working. Similarly, in another Turkish study, the majority lived in urban areas, with the most common occupation being housewife. 13 In a study conducted in the American population, patients with asthma had a high school or higher level of education (84.6%), lived in rural areas, and had heterogeneous income levels. 17 The differences between Turkish and American societies show that each society has its own characteristics.

We observed a positive correlation between the ACT score and education and household income levels. When examined on a regional basis, the number of patients with poor control was higher in the South‐eastern and Eastern Anatolia regions, which were regions with low literacy rates. In accordance with our results, another study found higher levels of education and federal poverty to be positively correlated with improved mean ACT scores. 18 When the data of elderly female patients in France were examined, women with low SES had more often uncontrolled asthma. 19 Azeez et al. showed that monthly income is the only predictor of good asthma control. 20 In another study, including African–American/Black and Hispanic/Latino populations, differences in ACT and Asthma Activities, Persistent, triGGers, Asthma medications, and Response to therapy (APGAR) were only observed at the education level when high school and below were compared with university and above. 21 A low education level may lead to poor adherence to treatment and inadequate inhaler device‐using skills, resulting in poor asthma control. 9 Limited knowledge of asthma management strategies, triggers, and symptoms contributes to this challenge. As income level increases, health accessibility increases, alleviating financial concerns. Having a higher household income was shown to be the only socioeconomic factor associated with better asthma control. 12 A study conducted in a Western Norwegian community demonstrated an increased frequency of asthma and respiratory symptoms among individuals with lower educational levels. 5 Additionally, increased asthma prevalence was associated with low educational levels 22 ; however, allergic diseases and asthma with atopy were associated with higher SES in other studies. 6 , 23

The factors underlying poor asthma control in individuals with low income are unknown, although there are studies suggesting that nutritional deficiencies might be a factor associated with poor asthma control 24 , 25 Simultaneously, one of the elements that contribute to inadequate asthma control might be insufficient access to healthcare services and the inability to afford treatment costs. The use of an inhaler corticosteroid (ICS)‐containing controller to improve symptom control, and lower the risk of exacerbations and asthma fatalities is essential in asthma management. 1 Low‐ and middle‐income countries have highly limited access to or cannot afford ICS‐containing inhalers. 26 Another contributing factor in low and middle‐income countries may be the use of biomass fuel for cooking, lighting, and heating, predisposing them to frequent acute asthma exacerbation and recurrent chest infections 27 ; however, these were not assessed in this study.

In most studies on SES, the patient's health insurance status was also determined. The absence of health insurance is indirectly associated with low income. Patients without health insurance were found less likely to receive regular asthma care, such as lower use of ICS (41%, 41%, and 29%; p < 0.001) and asthma specialist care (9%, 10%, and 4%; p < 0.001) that was recommended by the guidelines, even when their disease severity was higher. 28 A more recent study found that insurance coverage was associated with improved asthma control in adults aged 18–64 years from low SES households. 29 However, the use of private health insurance is highly limited in Turkey with only 0.7% of our patients having private health insurance; however, the insurance status of the patients was not evaluated in this study. Approximately 94% of them can access health services free of charge by the Social Insurance Institution. Covering health expenses by the social insurance institution in Turkey might further provide an advantage in terms of disease control.

Our results indicated that systemic corticosteroid use and hospitalization rates, which are undesirable consequences of impaired asthma control, were higher in illiterate patients. A recent nationwide study evaluating pediatric asthmatics of the Korean population also associated low SES with increased systemic steroid use and hospitalization rates. 30 Additionally, we observed a higher need for systemic corticosteroid use in the employees, which may depend on the occupational exposures to both sensitizers and irritants associated with current adult‐onset asthma and uncontrolled asthma. 31 The desire to shorten the exacerbation periods and prevent the reduction in the number of days worked may be other possible reasons for the higher use of steroids. Despite free healthcare services in Turkey, unemployed patients may not seek hospital care owing to financial concerns.

Limited access to foods, a sedentary lifestyle, smaller family size, the use of antibiotics, environmental pollution, and migration have all been identified as risk factors for asthma. These factors are related to environmental and lifestyle changes brought on by urbanization. 32 Although multivariate analyses do not support this, we found higher rates of hospitalization and ICU admission in patients born in rural areas in univariate analyses and higher rates of ICU admission in residents in urban. Limited data show that rural patients generally have difficulties in accessing health services, which suggests that they receive inadequate care for asthma. 33 , 34 The availability of insurance was linked to higher rates of hospitalization for asthma in non‐rural areas; however, in rural areas, income, occupation, and the proportion of people who do not speak English as their first language were linked to lower rates in another study. 35

All societies have different dynamics owing to geographical, ethnic, and financial differences; therefore, the results related to SES may not be compatible with the structure of each society. For instance, in Canada, lower SES was not related to poor asthma‐related quality of life. 36 Inequalities within and even between communities have been repeatedly documented worldwide, including in countries with publicly supported health systems. 37 Therefore, each society should be evaluated on its merits.

Since a large number of participants from many centers from every region of the country were included, we believe that the patient group objectively reflects the socioeconomic level of the Turkish adult patient population with asthma.

The retrospective study design limited our ability to evaluate other parameters reflecting SES. Additionally, it is important to note that asthma patients included in the study were part of a group with more hospital admissions due to uncontrolled asthma, which could potentially impact the results.

In conclusion, the national asthma database study provides valuable insights into the demographics, and phenotypic categories of asthma in the Turkish population, shedding light on the intricate relationship between SES and asthma control. Consequently, low SES can be considered a risk factor for asthma exacerbations and uncontrolled asthma. Identification of social markers in asthma and better recognition of risk factors based on the population gives us clues to provide better asthma control in the future. In light of these markers, specific populations can be identified, and tailored approaches to asthma management can be performed for these groups. A more significant disease burden means a higher cost of society. The findings of this study may raise awareness of these significant risk factors and provide information on potential avenues for preventing fatal or near‐fatal asthma. Social policies aiming to increase the education level of the population and to improve access to health care or to reduce environmental triggers should be prioritized.

AUTHOR CONTRIBUTIONS

Bahar Arslan: Writing ‐ original draft; Writing ‐ review and editing; Investigation; Validation. Murat Tuerk: Writing ‐ original draft; Writing ‐ review and editing; Methodology; Data curation; Conceptualization; Investigation. Serhat Hayme: Data curation; Validation. Omuer Aydin: Conceptualization; Investigation; Methodology; Validation. Derya Gokmen: Data curation; Software. Gozde Koycu Buhari: Investigation; Methodology. Zeynep Celebi Sozener: Conceptualization; Investigation; Methodology. Bilun Gemicioglu: Supervision; Investigation; Methodology. Ismet Bulut: Investigation; Methodology. Sengul Beyaz: Investigation; Methodology. Cihan Orcen: Investigation; Validation. Secil Kepil Ozdemir: Investigation; Methodology. Metin Keren: Methodology; Investigation. Ebru Damadoglu: Investigation; Methodology. Tugce Yakut: Investigation; Methodology. Ayse Fusun Kalpaklioglu: Investigation; Methodology; Conceptualization. Ayse Baccioglu: Investigation; Methodology; Conceptualization. Sumeyra Alan Yalim: Investigation; Validation. Insu Yilmaz: Investigation; Validation; Methodology. Ilkay Koca Kalkan: Investigation; Methodology. Elif Yelda Ozgun Niksarlioglu: Investigation; Validation. Ali Fuat Kalyoncu: Conceptualization; Investigation; Writing ‐ original draft; Methodology. Gul Karakaya: Investigation; Methodology. Muge Erbay: Investigation; Methodology. Sibel Nayci: Investigation; Validation. Fatma Merve Tepetam: Investigation; Methodology. Asli Akkor Gelincik: Investigation; Validation; Methodology. Hulya Dirol: Investigation; Validation. Ozlem Goksel: Investigation; Validation. Selen Karaoglanoglu: Investigation; Validation. Ferda Oner Erkekol: Investigation; Validation. Sacide Rana Isik: Investigation; Validation. Fusun Yildiz: Investigation; Validation. Yasemin Yavuz: Investigation; Validation. Dilek Karadogan: Investigation; Validation. Nurgul Bozkurt: Investigation; Validation. Ummuhan Seker: Investigation; Validation. Ipek Kivilcim Oguzulgen: Investigation; Validation. Ilknur Basyigit: Investigation; Validation. Serap Argun Baris: Investigation; Validation. Elif Yilmazel Ucar: Investigation. Tuba Erdogan: Investigation; Validation. Mehmet Polatli: Investigation; Validation. Dane Ediger: Investigation; Validation. Fatma Esra Gunaydin: Investigation; Validation. Leyla Pur: Investigation; Validation. Zeynep Yegin Katran: Investigation; Validation. Yonca Sekibag: Investigation; Validation. Enes Furkan Aykac: Investigation; Validation. Dilsad Mungan: Conceptualization; Investigation; Methodology. Ozcan Gul: Investigation; Validation. Ali Cengiz: Investigation; Validation. Bulent Akkurt: Investigation; Validation. Seyma Ozden: Investigation; Validation. Semra Demir: Investigation; Validation. Derya Unal: Investigation; Validation. Ayse Feyza Aslan: Investigation; Validation. Ali Can: Investigation; Validation. Reyhan Gumusburun: Investigation. Gulhan Bogatekin: Validation; Investigation. Hatice Serpil Akten: Investigation; Validation. Sinem Inan: Investigation; Validation. Munevver Erdinc: Investigation; Validation. Aliye Candan Ogus: Investigation. Murat Kavas: Investigation. Demet Polat Yulug: Validation; Investigation. Mehmet Erdem Cakmak: Investigation. Saltuk Bugra Kaya: Investigation; Validation. Gulistan Alpagat: Investigation; Validation. Eylem Sercan Ozgur: Investigation; Validation. Oguz Uzun: Investigation; Validation. Sule Tas Gulen: Investigation; Validation. Gulseren Pekbak: Investigation; Validation. Deniz Kizilirmak: Investigation; Validation. Yavuz Havlucu: Investigation; Validation. Halil Donmez: Investigation; Validation. Gulden Pacaci Cetin: Validation; Investigation. Sadan Soyyigit: Investigation; Validation. Bilge Yilmaz Kara: Validation; Investigation. Gulden Pasaoglu Karakis: Investigation; Validation. Adile Berna Dursun: Investigation; Validation; Methodology. Resat Kendirlinan: Investigation; Validation. Ayse Bilge Ozturk: Investigation; Validation. Can Sevinc: Investigation; Validation. Gokcen Omeroglu Simsek: Investigation; Validation. Oznur Abadoglu: Investigation; Validation. Pamir Cerci: Investigation; Validation. Taskin Yucel: Investigation; Validation. Irfan Yorulmaz: Investigation; Validation. Zahide Ciler Tezcaner: Investigation; Validation. Emel Cadalli Tatar: Investigation; Validation. Ahmet Emre Suslu: Investigation; Validation. Serdar Ozer: Investigation; Validation. Engin Dursun: Investigation; Validation. Arzu Yorgancioglu: Conceptualization; Investigation; Validation; Methodology. Gulfem Elif Celik: Conceptualization; Investigation; Methodology; Visualization; Writing ‐ review and editing; Formal analysis; Supervision. Mehmet Atilla Uysal: Supervision; Investigation; Methodology.

CONFLICT OF INTEREST STATEMENT

All authors declare that they do not have any potential conflicts of interest in relation to any aspect of this work.

Supporting information

Supplementary Material

CLT2-15-e70018-s001.docx (18.5KB, docx)

ACKNOWLEDGEMENTS

The authors thank the Turkish Thoracic Society for their unconditional support of the Turkish Adult Asthma Registry and the Chiesi Scientific Network for their English editing and proofreading of the present study.

Arslan B, Türk M, Hayme S, et al. Socioeconomic status has direct impact on asthma control: Turkish adult asthma registry. Clin Transl Allergy. 2025;e70018. 10.1002/clt2.70018

REFERENCES

  • 1. Global Inıtiative for Asthma . Global strategy for asthma management and prevention. 2023. www.ginasthma.org
  • 2. Global regional. National age‐sex‐specific mortality for 282 causes of death in 195 countries and territories, 1980–2017: a systematic analysis for the Global Burden of Disease Study 2017. Lancet. 2018;392(10159):1736‐1788. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 3. Trikamjee T, Comberiati P, Peter J. Pediatric asthma in developing countries: challenges and future directions. Curr Opin Allergy Clin Immunol. 2022;22(2):80‐85. 10.1097/aci.0000000000000806 [DOI] [PubMed] [Google Scholar]
  • 4. Agarwal A. Social classification: the need to update in the present scenario. Indian J Community Med. 2008;33(1):50‐51. 10.4103/0970-0218.39245 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 5. Ellison‐Loschmann L, Sunyer J, Plana E, et al. Socioeconomic status, asthma and chronic bronchitis in a large community‐based study. Eur Respir J. 2007;29(5):897‐905. 10.1183/09031936.00101606 [DOI] [PubMed] [Google Scholar]
  • 6. Uphoff E, Cabieses B, Pinart M, Valdés M, Antó JM, Wright J. A systematic review of socioeconomic position in relation to asthma and allergic diseases. Eur Respir J. 2015;46(2):364‐374. 10.1183/09031936.00114514 [DOI] [PubMed] [Google Scholar]
  • 7. Raju S, Siddharthan T, McCormack MC. Indoor air pollution and respiratory health. Clin Chest Med. 2020;41(4):825‐843. 10.1016/j.ccm.2020.08.014 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 8. Cardet JC, Louisias M, King TS, et al. Income is an independent risk factor for worse asthma outcomes. J Allergy Clin Immunol. 2018;141(2):754‐760.e3. 10.1016/j.jaci.2017.04.036 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 9. Williams MV, Baker DW, Honig EG, Lee TM, Nowlan A. Inadequate literacy is a barrier to asthma knowledge and self‐care. Chest. 1998;114(4):1008‐1015. 10.1378/chest.114.4.1008 [DOI] [PubMed] [Google Scholar]
  • 10. Basagaña X, Sunyer J, Kogevinas M, et al. Socioeconomic status and asthma prevalence in young adults: the European Community Respiratory Health Survey. Am J Epidemiol. 2004;160(2):178‐188. 10.1093/aje/kwh186 [DOI] [PubMed] [Google Scholar]
  • 11. Almqvist C, Pershagen G, Wickman M. Low socioeconomic status as a risk factor for asthma, rhinitis and sensitization at 4 years in a birth cohort. Clin Exp Allergy. 2005;35(5):612‐618. 10.1111/j.1365-2222.2005.02243.x [DOI] [PubMed] [Google Scholar]
  • 12. Ozden Sertcelik U, Damadoglu E, Karakaya G, Demir AU, Kalyoncu AF. Impact of socioeconomic factors and house cleaning on asthma control in women. Allergy Asthma Proc. 2022;43(2):140‐147. 10.2500/aap.2022.43.210003 [DOI] [PubMed] [Google Scholar]
  • 13. Konar NM, Karaismailoğlu E, Ertürk A. Sociodemographic and clinical characteristics of adult asthma patients: a cross‐sectional study. Forbes J Med. 2023;4.2. [Google Scholar]
  • 14. Celik GE, Aydin O, Gokmen D, et al. Picturing asthma in Turkey: results from the Turkish adult asthma registry. J Asthma. 2023;60(11):1‐14. 10.1080/02770903.2023.2206902 [DOI] [PubMed] [Google Scholar]
  • 15. Thomas M, Kay S, Pike J, et al. The Asthma Control Test (ACT) as a predictor of GINA guideline‐defined asthma control: analysis of a multinational cross‐sectional survey. Prim Care Respir J. 2009;18(1):41‐49. 10.4104/pcrj.2009.00010 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 16. Nathan RA, Sorkness CA, Kosinski M, et al. Development of the asthma control test: a survey for assessing asthma control. J Allergy Clin Immunol. 2004;113(1):59‐65. 10.1016/j.jaci.2003.09.008 [DOI] [PubMed] [Google Scholar]
  • 17. Fuhlbrigge AL, Adams RJ, Guilbert TW, et al. The burden of asthma in the United States: level and distribution are dependent on interpretation of the national asthma education and prevention program guidelines. Am J Respir Crit Care Med. 2002;166(8):1044‐1049. 10.1164/rccm.2107057 [DOI] [PubMed] [Google Scholar]
  • 18. Ganti P, Suman A, Chaudhary S, Sangha B, David L, Sekhsaria S. The effect of the socioeconomic status on the measurement of asthma control. Allergy Asthma Proc. 2022;43(1):e11‐e16. 10.2500/aap.2022.43.210103 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 19. Temam S, Chanoine S, Bédard A, et al. Low socioeconomic position and neighborhood deprivation are associated with uncontrolled asthma in elderly. Respir Med. 2019;158:70‐77. 10.1016/j.rmed.2019.09.010 [DOI] [PubMed] [Google Scholar]
  • 20. Azeez IA, Ladipo MM, Ige OM. Assessment of socioeconomic status and control of asthma in adults. Ann Ib Postgrad Med. 2016;14(2):85‐91. [PMC free article] [PubMed] [Google Scholar]
  • 21. Yawn BP, Ericson B, Cui J, et al. Comparing asthma control assessment using the asthma control test and the asthma APGAR in African American/Black and Hispanic/Latinx populations. J Asthma. 2023;60(8):1592‐1600. 10.1080/02770903.2022.2164201 [DOI] [PubMed] [Google Scholar]
  • 22. Eagan TM, Gulsvik A, Eide GE, Bakke PS. The effect of educational level on the incidence of asthma and respiratory symptoms. Respir Med. 2004;98(8):730‐736. 10.1016/j.rmed.2004.02.008 [DOI] [PubMed] [Google Scholar]
  • 23. Lee KS, Rha YH, Oh IH, Choi YS, Choi SH. Socioeconomic and sociodemographic factors related to allergic diseases in Korean adolescents based on the Seventh Korea Youth Risk Behavior Web‐based Survey: a cross‐sectional study. BMC Pediatr. 2016;16(1):19. 10.1186/s12887-016-0549-2 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 24. Litonjua AA, Weiss ST. Is vitamin D deficiency to blame for the asthma epidemic? J Allergy Clin Immunol. 2007;120(5):1031‐1035. 10.1016/j.jaci.2007.08.028 [DOI] [PubMed] [Google Scholar]
  • 25. Brehm JM, Schuemann B, Fuhlbrigge AL, et al. Serum vitamin D levels and severe asthma exacerbations in the Childhood Asthma Management Program study. J Allergy Clin Immunol. 2010;126(1):52‐58.e5. 10.1016/j.jaci.2010.03.043 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 26. Mortimer K, Reddel HK, Pitrez PM, Bateman ED. Asthma management in low and middle income countries: case for change. Eur Respir J. 2022;60(3):2103179. 10.1183/13993003.03179-2021 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 27. Gordon SB, Bruce NG, Grigg J, et al. Respiratory risks from household air pollution in low and middle income countries. Lancet Respir Med. 2014;2(10):823‐860. 10.1016/s2213-2600(14)70168-7 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 28. Hasegawa K, Stoll SJ, Ahn J, Kysia RF, Sullivan AF, Camargo CA, Jr. Association of insurance status with severity and management in ED patients with asthma exacerbation. West J Emerg Med. 2016;17(1):22‐27. 10.5811/westjem.2015.11.28715 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 29. Suri R, Macinko J, Inkelas M, Needleman J. The relationship between insurance status and the affordable care act on asthma outcomes among low‐income US adults. Chest. 2022;161(6):1465‐1474. 10.1016/j.chest.2022.01.011 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 30. Lee WS, Hwang JK, Ryu J, et al. The relationship between childhood asthma and socioeconomic status: a Korean nationwide population‐based study. Front Public Health. 2023;11:1133312. 10.3389/fpubh.2023.1133312 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 31. Sit G, Varraso R, Fezeu LK, et al. Occupational exposures to irritants and sensitizers, asthma and asthma control in the nutrinet‐Santé cohort. J Allergy Clin Immunol Pract. 2022;10(12):3220‐3227.e7. 10.1016/j.jaip.2022.08.047 [DOI] [PubMed] [Google Scholar]
  • 32. Hertzen L von, Haahtela T. Disconnection of man and the soil: reason for the asthma and atopy epidemic? J Allergy Clin Immunol. 2006;117(2):334‐344. 10.1016/j.jaci.2005.11.013 [DOI] [PubMed] [Google Scholar]
  • 33. Lum EY, Sharpe HM, Nilsson C, et al. Urban and rural differences in the management of asthma among primary care physicians in Alberta. Can J Clin Pharmacol. 2007;14(3):e275‐e282. [PubMed] [Google Scholar]
  • 34. Valet RS, Perry TT, Hartert TV. Rural health disparities in asthma care and outcomes. J Allergy Clin Immunol. 2009;123(6):1220‐1225. 10.1016/j.jaci.2008.12.1131 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 35. McGrath RJ, Stransky ML, Seavey JW. The impact of socioeconomic factors on asthma hospitalization rates by rural classification. J Community Health. 2011;36(3):495‐503. 10.1007/s10900-010-9333-7 [DOI] [PubMed] [Google Scholar]
  • 36. Bacon SL, Bouchard A, Loucks EB, Lavoie KL. Individual‐level socioeconomic status is associated with worse asthma morbidity in patients with asthma. Respir Res. 2009;10(1):125. 10.1186/1465-9921-10-125 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 37. Sullivan K, Thakur N. Structural and social determinants of health in asthma in developed economies: a scoping review of literature published between 2014 and 2019. Curr Allergy Asthma Rep. 2020;20(2):5. 10.1007/s11882-020-0899-6 [DOI] [PMC free article] [PubMed] [Google Scholar]

Associated Data

This section collects any data citations, data availability statements, or supplementary materials included in this article.

Supplementary Materials

Supplementary Material

CLT2-15-e70018-s001.docx (18.5KB, docx)

Articles from Clinical and Translational Allergy are provided here courtesy of Wiley

RESOURCES